Page 2 - Nir Friedman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunotherapy has sparked new hope for people with cancer, but for it to work, the patient’s immune system must be able to “see” the tumor. There are

An end to invasive biopsies? A simple, inexpensive blood test could diagnose a wide array of diseases including cancers, liver diseases, immune disorders and more. Israa Sharkia preparing blood samples for DNA sequencing. Photo courtesy of Hebrew University of Jerusalem Nobody enjoys getting a biopsy, where a tissue sample is surgically taken and analyzed in a lab for signs of disease such as cancer. It’s not only unpleasant for the patient, but also has clinical drawbacks: a biopsy doesn’t always extract the diseased tissue and isn’t helpful in detecting disease at early stages. Thes...

the potential to diagnose a wide array of diseases. By Yakir Benzion, United With Israel Getting seriously sick is never fun and often very complicated when invasive tests are required, but an Israeli research team has developed a new blood test has the potential to diagnose a wide array of diseases – including cancers, liver diseases, immune disorders and other illnesses – without the need for painful and sometimes dangerous biopsies. Using advanced techniques that track the DNA from different parts of the body, the test has proven to be extremely accurate with the ability to report on t...

Credit: Hebrew University of Jerusalem In diagnostic medicine, biopsies, where a sample of tissue is extracted for analysis, is a common tool for the detection of many conditions. But this approach has several drawbacks - it can be painful, doesn't always extract the diseased tissue, and can only be used in a sufficiently advanced disease stage, making it, in some cases, too late for intervention. These concerns have encouraged researchers to find less invasive and more accurate options for diagnoses. Professor Nir Friedman and Dr. Ronen Sadeh of the Life Sciences Institute and School of Co...